Fresenius Kabi Iodixanol Injection, USP is the first FDA-approved generic that is fully substitutable for Visipaque® LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the United States, starting immediately with the launch of Iodixanol Injection, USP, a product the U.S. Food and Drug Administration (FDA) … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Singlecell Technology Market Landscape 2022” report has been added to ResearchAndMarkets.com’s offering. The global single-cell technology (SCT) market has emerged since the mid-2010s. The SCT is defined as any cell biology research tool that provides single cell (SC) resolution handling and data sets, for example, SC-picking up/dispensing, SC-sequencing, and SC-protein analysis technologies. There … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Contraceptives Market Analysis by Product (Topical, Oral Contraceptive Pills, Injectable Contraceptives), by Device (Male Condoms, Diaphragms, Female Condoms, Vaginal Rings, Sub Dermal Implants, Intra-Uterine Devices), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global contraceptives market size is estimated to be USD 23.52 billion in 2021 … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) today announced that Michael (Mike) Ullmann will retire from his position as Executive Vice President, General Counsel at the end of this year, following 33 years of leadership and service to the Company. Throughout his distinguished career, Mr. Ullmann has worked with the organization’s Board of Directors … [Read more…]
Australian health insurer boosts personalization, improves member value, and supports business compliance with connected data framework CHESTERBROOK, Pa.–(BUSINESS WIRE)–Boomi™, the intelligent connectivity and automation leader, today announced that Peoplecare, an Australian health insurance mutual fund, implemented The Boomi AtomSphere™ Platform to deliver improved member experiences and personalized health insurance with connected, accurate, and accessible data. … [Read more…]
Follows FDA Breakthrough Device Designation and clinical evidence of a Therapeutic Alliance HealthQuad and British International Investment (BII) join earlier investors W Health Ventures, Kae Capital, pi Ventures and Google Assistant Investments Funds will enable access to clinically evidenced digital therapeutics (DTx) in the US, UK, India and other global markets Will enable further reach … [Read more…]
Project to support identification of Bax and Bak inhibitor therapeutic candidates with the potential to treat ALS and other neurodegenerative diseases CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced a two-year sponsored research agreement with Sunnybrook Research Institute (SRI) to expedite the identification of novel drug candidates that inhibit Bax … [Read more…]
HITRUST Risk-based, 2-year Certification validates HNI Healthcare is committed to meeting key regulations and protecting sensitive information AUSTIN, Texas–(BUSINESS WIRE)–HNI Healthcare (HNI), a technology-enabled and data-driven physician practice management company, announces that their VitalsMD® proprietary software has earned certified status for information security by HITRUST. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization’s … [Read more…]
Smart technology features humeral planning and other major enhancements that offer surgeons a complete view of patient solutions GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, today announces the U.S. release of the Equinoxe® Shoulder Planning App v2.1, giving surgeons increased flexibility to plan shoulder … [Read more…]
NHS-Galleri Trial is Evaluating Clinical Utility of GRAIL’s Galleri®, a Multi-Cancer Early Detection Test, Alongside Current Standard of Care in England NHS-Galleri Trial Prioritized Equitable Recruitment Approaches Designed to Achieve Representation of People from Minority Ethnic Backgrounds MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can … [Read more…]
